| 8:35 am |
Introductory Remarks (Co-organizers)
 Video Presentation |
9:00 am
9:30 am
|
New Models in Technology Transfer
Delivering Innovation to the Global Market
Nava Swersky Sofer, Former CEO, Yissum Technology Transfer Company
Video Presentation
The Centre for Drug Research and Development:
A Hybrid Approach to Bridging the Commercialization Gap
Natalie Dakers, CEO, Centre for Drug Research and Development
Presentation not available
|
| 10:00 am |
Coffee Break and Networking |
|
Showcased Technologies
Therapeutic Candidates |
Showcased Technologies
Technology Platforms |
10:20
to
12:00 |
10 Technology
presentations |
10 Technology
presentations |
| 10:20 am |
Putting Cancer on Stasis
Presented by: Dr. Pierre Hardy
 (Univalor VAL-616 HSJ)
Video Presentation
|
Transient Expression in CHO Cells, a More Efficient and Productive Method
Presented by: Dr. Yves Durocher
(NRC-BRI 11992)
Video Presentation
|
| 10:30 am |
Anticancer Vitamin D Agonists with HDAC Inhibitory Activity
Presented by: Dr. John H. White
(McGill 06069)
Video Presentation
|
Production of Glycosylated Interferon α2b for Biogeneric Application
Presented by: Dr. Yves Durocher
(NRC-BRI 11993)
Video Presentation
|
| 10:40 am |
Antisense Inhibitors of Demethylase/Mbd2 for Anticancer Therapy
Presented by: Dr. Moshe Szyf
(McGill 02136)
Video Presentation
|
Troponin Derivated Muscle Promoters for Gene Therapy
Presented by: Dr. Rénald Gilbert
(NRC-BRI 11887)
Video Presentation
|
| 10:50 am |
Potent VEGF Inhibitor
Presented by: Dr. Yves Durocher
(NRC-BRI 11885)
Video Presentation
|
HEK293 Master Cell Bank for cGMP Production of Biopharmaceutical
Presented by: Dr. Amine Kamen
(NRC-BRI 10894)
Video Presentation
|
| 11:00 am |
Ligand Directed to Human Clusterin
Presented by: Dr. Maureen O'Connor
(NRC-BRI 12095)
Video Presentation
|
A New Chemistry Platform for RNA Interference
Presented by: Dr. Masad Damha
(McGill 06052)
Video Presentation
|
| 11:10 am |
Circulating Microvesicles as Cancer Biomarkers
Presented by: Dr. Janusz Rak
(McGill 07107)
Video Presentation
|
Survival of the Fittest Red Blood Cell
Presented by: Dr. Edouard Kouassi
(Univalor VAL-648 HMR)
Video Presentation
|
| 11:20 am |
Engineered Biosynthetic Pathway for Sialic Acid Analogs and its Use for the Development of Anti-Infective
Presented by: Dr. Dennis Whitfield
(NRC-IBS 12033)
Video Presentation
|
Label-Free Biological Measurement Using SPR
Presented by: Dr. Jean-François Masson
(Univalor VAL-625 UM)
Video Presentation
|
| 11:30 am |
Deoxyribozyme Therapeutic Platform for HCV
Presented by: Dr. Carolina Alfieri
(Univalor VAL-425 HSJ)
Video Presentation
|
Delivering that Antigen to the Right Spot
Presented by: Dr. Réjean Lapointe
(Univalor VAL-678 CHUM)
Video Presentation
|
| 11:40 am |
A New Modality for Inhibition of Viral Infections
Presented by: Dr. Nahum Sonenberg
(McGill 08047)
Video Presentation
|
Biomolecular Tweezers for Antagonists Protein-protein Interactions
Presented by: Dr. Feng Ni
(NRC-BRI 11615)
Video Presentation
|
| 11:50 am |
Transplantation: Selecting the Best Donors
Presented by: Dr. Guillaume Roy
(Univalor VAL-652-MULTI)
Video Presentation
|
A Novel System for Identifying and Characterizing Axon Growth and Guidance Molecules
Presented by: Dr. Frédéric Charron
(Univalor VAL-587 IRCM)
Presentation not available
|
| 12:10 pm |
Lunch and Networking |
| 1:30 pm |
Anti-Apoptotic Antibodies
Presented by: Dr. Jamshid Tanha
(NRC-IBS 11749)
Video Presentation
|
Synthetic Ether Lipid (Archaeosome) Delivery / Adjuvant Technology
Presented by: Dr. Dennis Sprott
(NRC-IBS 11784)
Video Presentation
|
| 1:40 pm |
Human Soluble VH and VL Single-Domain Antibody Libraries for Developing Human Therapeutic Applications
Presented by: Dr. Jamshid Tanha
(NRC-IBS 11686)
Video Presentation
|
Mycobacterial Lipids for Use in Vaccine-Delivery Liposomes with an Adjuvant Effect
Presented by: Dr. Lakshmi Krishnan
(NRC-IBS 11305)
Video Presentation
|
| 1:50 pm |
Age-Related Macular Degeneration Drying up Development of the Dry Form of AMD
Presented by: Dr. Stéphanie Larose
(Univalor VAL-620-Multi)
Video Presentation
|
Vector Technology to Deliver Neurotherapeutics across the Blood Brain Barrier
Presented by: Dr. Danica Stanimirovic
(NRC-IBS 11085)
Video Presentation
|
| 2:00 pm |
D-isoproterenol as an Anti-Diabetic Cataract Compound and for Delaying Formation of Retinopathy
Presented by: Dr. Yasuo Konishi
(NRC-BRI 11864)
Video Presentation
|
A Biological CCR2 Antagonist with Immunosuppressive and Anticancer Properties
Presented by: Dr. Astrid Reimann
(McGill 08079)
Video Presentation
|
| 2:10 pm |
Bacterial Components for Allergic Airway Disorder Therapy
Presented by: Dr. Wangxue Chen
(NRC-IBS 11894)
Video Presentation
|
Multi-Modal Imaging Agents for Molecular Imaging of Cancer
Presented by: Dr. Abedelnasser Abulrob
(NRC-IBS 12075)
Video Presentation
|
| 2:20 pm |
PD-1 BioTool and PD-1 Targets
Presented by: Dr. Elias Haddad
(Univalor VAL-568/569 UM)
Video Presentation
|
Novel Algorithm for Finding Robust Cancer Gene Markers
Presented by: Dr. Edwin Wang
(NRC-BRI 12020)
Video Presentation
|
| 2:30 pm |
Novel Peptide for the Treatment of Alzheimer's Disease
Presented by: Dr. Balu Chakravarthy
(NRC-IBS 11630)
Video Presentation
|
Epigallocatechin Gallate Prodrugs as Anticancer Agents
Presented by: Dr. Tak-Hang Chan
(McGill 05062)
Video Presentation
|
| 2:40 pm |
PCSK9 and Cardiovascular Diseases
Presented by: Dr. Nabil G. Seidah
(Univalor VAL-503 IRCM)
Video Presentation
|
Receptor Traps
Presented by: Dr. Maureen O'Connor
NRC-BRI 11817)
Video Presentation
|
| 2:50 pm |
Fenretinide Corrects Lipid Imbalance in Cystic Fibrosis (CF) and Pseudomonas Clearance from the Infected CF Lungs
Presented by: Dr. Danuta Radzioch
(McGill 06031)
Video Presentation
|
Novel Peptide(s) for the Treatment of Cancer
Presented by: Dr. Maria Moreno
(NRC-IBS 11627)
Video Presentation
|
| 3:00 pm |
5'-OXO-ETE Receptor Antagonists
Presented by: Dr. William Powell
(McGill 09044)
Video Presentation
|
A Breast Cancer Prognostic Test for Enhanced Clinical Outcome
Presented by: Dr. Nicholas Bertos
(McGill 07033)
Video Presentation
|
| 3:20 pm |
Coffee Break and Networking |
3:40 pm
4:10 pm
4:40 pm |
Industrial Technology Drivers
Opportunities in the Public-private Interface for Drug Discovery
Michael Luther, President, David H. Murdock Research Institute
Video Presentation
Feeding the Beast: A Seller's Guide to Filling a Big Bio Pipeline
John Hebert, Associate Director, Corporate Development, Genzyme Corporation
Video Presentation
An Evolving Pharma Model for External Collaboration
Reid J. Leonard, Executive Director, Licensing and External Research, Merck & Co.
Presentation not available
|
| 5:10 pm |
Closing |
